Skip to main content
NIH funding notice RFA-AI-20-015

Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)

Closed on July 28, 2020.

Posted
March 9, 2020
Close date
July 28, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,792,133 in first-year total cost, median $858,911.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 JP-A (J1)]4

Most frequent institutions

  1. MASSACHUSETTS INSTITUTE OF TECHNOLOGY2
  2. HDT BIO CORPORATION1
  3. SCRIPPS RESEARCH INSTITUTE, THE1
Competing awards under RFA-AI-20-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies1R61AI161818-01ANDRABI, RAIEES AHMADSHAW, GEORGE MSCRIPPS RESEARCH INSTITUTE, THE, CA$1,505,564ZAI1
2021Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine1R61AI161811-01KHANDHAR, AMIT PRAFULHDT BIO CORPORATION, WA$927,069ZAI1
2021Immune engineering of optimized sequential immunization strategies for HIV vaccines1R61AI161297-01CROTTY, SHANE PIRVINE, DARRELL JMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$790,753ZAI1
2021Combinatorial and computational design of bnAb mRNA vaccines for HIV1R61AI161805-01ANDERSON, DANIEL GMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$568,747ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-20-015: Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) | ScienceDex | ConductScience